We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$136M
AUM Growth
+$1.33M
Cap. Flow
-$2.17M
Cap. Flow %
-1.59%
Top 10 Hldgs %
21.77%
Holding
187
New
33
Increased
43
Reduced
61
Closed
33

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$1.43M
2
MLM icon
Martin Marietta Materials
MLM
+$1.31M
3
EXPD icon
Expeditors International
EXPD
+$1.16M
4
LPX icon
Louisiana-Pacific
LPX
+$890K
5
CCL icon
Carnival Corporation Ltd
CCL
+$839K

Top Sells

Rank Stock Value
1
PRXL
Parexel International Corp
PRXL
+$2.14M
2
NSC icon
Norfolk Southern
NSC
+$1.25M
3
MS icon
Morgan Stanley
MS
+$1.13M
4
AMGN icon
Amgen
AMGN
+$1,000K
5
TD icon
Toronto Dominion Bank
TD
+$913K

Sector Composition

Rank Sector Weight
1 Industrials 23.47%
2 Healthcare 19.52%
3 Financials 17.24%
4 Consumer Staples 11.65%
5 Technology 11.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.B icon
51
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.05M 0.77%
5,750
-400
-7% -$70.7K
ACM icon
52
Aecom
ACM
$9.63B
$1.02M 0.75%
27,800
+2,000
+8% +$65.7K
AGN
53
DELISTED
Allergan plc
AGN
$1.02M 0.75%
4,990
+540
+12% +$126K
VRSK icon
54
Verisk Analytics
VRSK
$24.7B
$973K 0.71%
11,700
+5,400
+86% +$447K
HON icon
55
Honeywell
HON
$76.3B
$962K 0.7%
7,513
-609
-7% -$75.5K
LPX icon
56
Louisiana-Pacific
LPX
$5.3B
$946K 0.69%
+34,920
New +$890K
PG icon
57
Procter & Gamble
PG
$342B
$941K 0.69%
10,346
+75
+0.7% +$6.83K
DAL icon
58
Delta Air Lines
DAL
$60.5B
$909K 0.67%
18,841
+12,291
+188% +$613K
SLB icon
59
SLB Ltd
SLB
$76.5B
$881K 0.65%
12,636
-50
-0.4% -$3.31K
RTX icon
60
RTX Corp
RTX
$301B
$853K 0.63%
11,676
+691
+6% +$51.1K
KEY icon
61
KeyCorp
KEY
$24.3B
$849K 0.62%
45,095
+15,800
+54% +$286K
PWR icon
62
Quanta Services
PWR
$100B
$829K 0.61%
22,175
+2,125
+11% +$74.5K
ABBV icon
63
AbbVie
ABBV
$431B
$827K 0.61%
9,308
+4,700
+102% +$358K
K
64
DELISTED
Kellanova
K
$821K 0.6%
14,015
– –
CLX icon
65
Clorox
CLX
$12.8B
$811K 0.59%
6,150
-150
-2% -$20.2K
GWR
66
DELISTED
Genesee & Wyoming Inc.
GWR
$804K 0.59%
+10,870
New +$744K
SYY icon
67
Sysco
SYY
$40.4B
$795K 0.58%
14,740
-650
-4% -$33.8K
WT icon
68
WisdomTree
WT
$3.26B
$776K 0.57%
76,250
+3,800
+5% +$36.8K
SNA icon
69
Snap-on
SNA
$21.5B
$765K 0.56%
5,136
-1,275
-20% -$192K
HQY icon
70
HealthEquity
HQY
$8.65B
$759K 0.56%
15,010
+7,850
+110% +$365K
GOOG icon
71
Alphabet (Google) Class C
GOOG
$4.36T
$754K 0.55%
15,720
+80
+0.5% +$3.73K
PEP icon
72
PepsiCo
PEP
$189B
$751K 0.55%
6,737
-273
-4% -$31.5K
UNP icon
73
Union Pacific
UNP
$175B
$741K 0.54%
6,389
-200
-3% -$21.5K
COL
74
DELISTED
Rockwell Collins
COL
$729K 0.53%
5,575
-450
-7% -$54.7K
FTNT icon
75
Fortinet
FTNT
$117B
$702K 0.51%
97,875
-9,500
-9% -$72.1K
1 2
3
4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return
FAFN
First Affirmative Financial Network Colorado Springs, Colorado $258M AUM

New England Research & Management's Q3 2017 Portfolio in Review

As of Q3 2017, New England Research & Management held 187 positions worth $136M, up 0.98% from $135M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q3 2017 filing shows 33 new, 43 increased, 61 reduced and 33 closed positions. Its largest new stake was Medtronic: 17,182 shares worth $1.34M. The largest sale was Parexel International Corp, an estimated $2.14M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q3 2017 buy was Medtronic: 17,182 shares worth $1.34M.
  • New England Research & Management added most to Carnival Corporation Ltd in Q3 2017, an estimated $839K increase.
  • New England Research & Management's biggest Q3 2017 reduction was Amgen, cutting an estimated $1,000K.
  • New England Research & Management fully exited Parexel International Corp in Q3 2017, selling an estimated $2.14M.
  • New England Research & Management's ten largest holdings make up 22% of its $136M portfolio in Q3 2017.
  • New England Research & Management opened 33 new positions and closed 33 in Q3 2017.
  • New England Research & Management's portfolio value rose 0.98% quarter-over-quarter to $136M.

Based on New England Research & Management's 13F filing for Q3 2017, filed 25 Oct 2017.